Article Versions Notes

Huang C-H, Wang S-C, Chen I-C, Chen Y-T, Liu P-L, Fang S-H, Huang S-P, Yeh H-C, Liu C-C, Lee P-Y, et al. Protective Effect of Piplartine against LPS-Induced Sepsis through Attenuating the MAPKs/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation. Pharmaceuticals. 2021; 14(6):588. https://doi.org/10.3390/ph14060588

Huang, Chi-Han, Shu-Chi Wang, I-Chen Chen, Yi-Ting Chen, Po-Len Liu, Shih-Hua Fang, Shu-Pin Huang, Hsin-Chih Yeh, Ching-Chih Liu, Po-Yen Lee, and et al. 2021. "Protective Effect of Piplartine against LPS-Induced Sepsis through Attenuating the MAPKs/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation" Pharmaceuticals 14, no. 6: 588. https://doi.org/10.3390/ph14060588

Huang, C.-H., Wang, S.-C., Chen, I.-C., Chen, Y.-T., Liu, P.-L., Fang, S.-H., Huang, S.-P., Yeh, H.-C., Liu, C.-C., Lee, P.-Y., Lin, T.-C., Cheng, W.-C., Su, C.-C., Wu, H.-E., Chen, Y.-R., & Li, C.-Y. (2021). Protective Effect of Piplartine against LPS-Induced Sepsis through Attenuating the MAPKs/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation. Pharmaceuticals, 14(6), 588. https://doi.org/10.3390/ph14060588